We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
Cap. Flow
-$2.07B
Cap. Flow %
-2.5%
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$433M
2
LOW icon
Lowe's Companies
LOW
+$277M
3
ORCL icon
Oracle
ORCL
+$226M
4
PGR icon
Progressive
PGR
+$220M
5
LVS icon
Las Vegas Sands
LVS
+$167M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Healthcare 15.3%
3 Industrials 15.12%
4 Technology 14.91%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
101
TJX Companies
TJX
$170B
$283M 0.34%
3,734,413
+1,194,374
+47% +$82.9M
MOH icon
102
Molina Healthcare
MOH
$10.3B
$282M 0.34%
887,426
-18,230
-2% -$5.42M
CAT icon
103
Caterpillar
CAT
$409B
$277M 0.33%
1,337,314
-274,409
-17% -$55.3M
OTIS icon
104
Otis Worldwide
OTIS
$27.4B
$277M 0.33%
3,178,078
-125,973
-4% -$10.5M
WELL icon
105
Welltower
WELL
$178B
$276M 0.33%
3,222,951
-25,897
-0.8% -$2.16M
ETR icon
106
Entergy
ETR
$54.1B
$271M 0.33%
4,815,240
-38,294
-0.8% -$2.01M
WCC
107
WESCO International
WCC
$16.2B
$270M 0.33%
2,051,198
-162,857
-7% -$20.8M
UNP icon
108
Union Pacific
UNP
$183B
$268M 0.32%
1,063,611
-45,349
-4% -$10.7M
REG icon
109
Regency Centers
REG
$15B
$265M 0.32%
3,523,333
-27,685
-0.8% -$2M
WH icon
110
Wyndham Hotels & Resorts
WH
$5.46B
$265M 0.32%
2,956,523
-53,973
-2% -$4.51M
CRH icon
111
CRH
CRH
$66.7B
$264M 0.32%
5,001,775
-244,418
-5% -$12.1M
UHS icon
112
Universal Health Services
UHS
$9.43B
$264M 0.32%
2,033,059
-20,356
-1% -$2.62M
OSK icon
113
Oshkosh
OSK
$9.67B
$261M 0.31%
2,318,807
-823,718
-26% -$90M
ST icon
114
Sensata Technologies
ST
$6.65B
$258M 0.31%
4,183,368
-176,438
-4% -$10.3M
AMGN icon
115
Amgen
AMGN
$203B
$255M 0.31%
1,135,035
+412,337
+57% +$87M
BWXT icon
116
BWX Technologies
BWXT
$16B
$255M 0.31%
5,321,919
+452,145
+9% +$23.7M
SGI
117
Somnigroup International
SGI
$15.1B
$251M 0.3%
5,342,081
+2,100,141
+65% +$95.2M
DVN icon
118
Devon Energy
DVN
$51.9B
$251M 0.3%
5,691,104
+3,616,599
+174% +$150M
FL
119
DELISTED
Foot Locker
FL
$249M 0.3%
5,714,380
+94,384
+2% +$4.48M
HAS icon
120
Hasbro
HAS
$12.6B
$248M 0.3%
2,431,930
+31,814
+1% +$3.05M
ITT icon
121
ITT
ITT
$17.5B
$240M 0.29%
2,347,906
-17,489
-0.7% -$1.71M
GL icon
122
Globe Life
GL
$13.5B
$236M 0.28%
2,516,888
+226,388
+10% +$20.9M
CUZ icon
123
Cousins Properties
CUZ
$5.29B
$231M 0.28%
5,716,233
-44,751
-0.8% -$1.76M
RNR icon
124
RenaissanceRe
RNR
$13.7B
$231M 0.28%
1,361,487
-34,988
-3% -$5.48M
AFL icon
125
Aflac
AFL
$63.9B
$230M 0.28%
3,941,817
-131,895
-3% -$7.39M

Similar funds

Boston Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
  • Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
  • Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
  • Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
  • Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
  • Boston Partners opened 59 new positions and closed 45 in Q4 2021.
  • Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.